Global Primary Hyperoxaluria Drug Industry Research Report 2020, Forecast to 2025

September 2020 | 100 pages | ID: GBCF46C4A7C1EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Primary Hyperoxaluria Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Primary Hyperoxaluria Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Primary Hyperoxaluria Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Primary Hyperoxaluria Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Primary Hyperoxaluria Drug market are discussed.

The market is segmented by types:

• ALLN-230
• DCR-PHXC
• ALN-GO1
• Others

It can be also divided by applications:

• Hospital
• Clinic
• Others

And this report covers the historical situation, present status and the future prospects of the global Primary Hyperoxaluria Drug market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Allena Pharmaceuticals Inc
• Intellia Therapeutics Inc
• Alnylam Pharmaceuticals Inc
• Dicerna Pharmaceuticals Inc
• OxThera AB

Report Includes:

• xx data tables and xx additional tables
• An overview of global Primary Hyperoxaluria Drug market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Primary Hyperoxaluria Drug market
• Profiles of major players in the industry, including Allena Pharmaceuticals Inc, Intellia Therapeutics Inc, Alnylam Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc, OxThera AB.....

Research Objectives

• To study and analyze the global Primary Hyperoxaluria Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Primary Hyperoxaluria Drug market by identifying its various subsegments.
• Focuses on the key global Primary Hyperoxaluria Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Primary Hyperoxaluria Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Primary Hyperoxaluria Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Primary Hyperoxaluria Drug Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Primary Hyperoxaluria Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 PRIMARY HYPEROXALURIA DRUG INDUSTRY OVERVIEW

2.1 Global Primary Hyperoxaluria Drug Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Primary Hyperoxaluria Drug Global Import Market Analysis
  2.1.2 Primary Hyperoxaluria Drug Global Export Market Analysis
  2.1.3 Primary Hyperoxaluria Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 ALLN-230
  2.2.2 DCR-PHXC
  2.2.3 ALN-GO1
  2.2.4 Others
2.3 Market Analysis by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
2.4 Global Primary Hyperoxaluria Drug Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Primary Hyperoxaluria Drug Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Primary Hyperoxaluria Drug Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Primary Hyperoxaluria Drug Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Primary Hyperoxaluria Drug Manufacturer Market Share
  2.4.5 Top 10 Primary Hyperoxaluria Drug Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Primary Hyperoxaluria Drug Market
  2.4.7 Key Manufacturers Primary Hyperoxaluria Drug Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Primary Hyperoxaluria Drug Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Primary Hyperoxaluria Drug Industry Impact
  2.7.1 How the Covid-19 is Affecting the Primary Hyperoxaluria Drug Industry
  2.7.2 Primary Hyperoxaluria Drug Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Primary Hyperoxaluria Drug Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Primary Hyperoxaluria Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL PRIMARY HYPEROXALURIA DRUG MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Primary Hyperoxaluria Drug Sales Market Share by Region
4.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2015-2019)
4.3 Global Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Primary Hyperoxaluria Drug Market Size Detail
  4.4.1 North America Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020)
  4.4.2 North America Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Primary Hyperoxaluria Drug Market Size Detail
  4.5.1 Europe Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020)
  4.5.2 Europe Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Primary Hyperoxaluria Drug Market Size Detail
  4.6.1 Japan Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020)
  4.6.2 Japan Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Primary Hyperoxaluria Drug Market Size Detail
  4.7.1 China Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020)
  4.7.2 China Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL PRIMARY HYPEROXALURIA DRUG MARKET SEGMENT BY TYPE

5.1 Global Primary Hyperoxaluria Drug Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Primary Hyperoxaluria Drug Sales and Market Share by Type (2015-2020)
  5.1.2 Global Primary Hyperoxaluria Drug Revenue and Market Share by Type (2015-2020)
5.2 ALLN-230 Sales Growth Rate and Price
  5.2.1 Global ALLN-230 Sales Growth Rate (2015-2020)
  5.2.2 Global ALLN-230 Price (2015-2020)
5.3 DCR-PHXC Sales Growth Rate and Price
  5.3.1 Global DCR-PHXC Sales Growth Rate (2015-2020)
  5.3.2 Global DCR-PHXC Price (2015-2020)
5.4 ALN-GO1 Sales Growth Rate and Price
  5.4.1 Global ALN-GO1 Sales Growth Rate (2015-2020)
  5.4.2 Global ALN-GO1 Price (2015-2020)
5.5 Others Sales Growth Rate and Price
  5.5.1 Global Others Sales Growth Rate (2015-2020)
  5.5.2 Global Others Price (2015-2020)

6 GLOBAL PRIMARY HYPEROXALURIA DRUG MARKET SEGMENT BY APPLICATION

6.1 Global Primary Hyperoxaluria DrugSales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)

7 GLOBAL PRIMARY HYPEROXALURIA DRUG MARKET FORECAST

7.1 Global Primary Hyperoxaluria Drug Sales, Revenue Forecast
  7.1.1 Global Primary Hyperoxaluria Drug Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Primary Hyperoxaluria Drug Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Primary Hyperoxaluria Drug Price and Trend Forecast (2020-2025)
7.2 Global Primary Hyperoxaluria Drug Sales Forecast by Region (2020-2025)
  7.2.1 North America Primary Hyperoxaluria Drug Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Primary Hyperoxaluria Drug Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Primary Hyperoxaluria Drug Production, Revenue Forecast (2020-2025)
  7.2.4 China Primary Hyperoxaluria Drug Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF PRIMARY HYPEROXALURIA DRUG INDUSTRY KEY MANUFACTURERS

8.1 Allena Pharmaceuticals Inc
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Allena Pharmaceuticals Inc News
8.2 Intellia Therapeutics Inc
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Intellia Therapeutics Inc News
8.3 Alnylam Pharmaceuticals Inc
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Alnylam Pharmaceuticals Inc News
8.4 Dicerna Pharmaceuticals Inc
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Dicerna Pharmaceuticals Inc News
8.5 OxThera AB
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 OxThera AB Primary Hyperoxaluria Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 OxThera AB News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Primary Hyperoxaluria Drug Picture
Figure Research Programs/Design for This Report
Figure Global Primary Hyperoxaluria Drug Market by Regions (2019)
Table Global Market Primary Hyperoxaluria Drug Comparison by Regions (M USD) 2019-2025
Table Global Primary Hyperoxaluria Drug Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Primary Hyperoxaluria Drug by Type in 2019
Figure ALLN-230 Picture
Figure DCR-PHXC Picture
Figure ALN-GO1 Picture
Figure Others Picture
Table Global Primary Hyperoxaluria Drug Sales by Application (2019-2025)
Figure Global Primary Hyperoxaluria Drug Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Primary Hyperoxaluria Drug Sales by Manufacturer (2018-2020)
Figure Global Primary Hyperoxaluria Drug Sales Market Share by Manufacturer in 2019
Table Global Primary Hyperoxaluria Drug Revenue by Manufacturer (2018-2020)
Figure Global Primary Hyperoxaluria Drug Revenue Market Share by Manufacturer in 2019
Table Global Primary Hyperoxaluria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Primary Hyperoxaluria Drug Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Primary Hyperoxaluria Drug Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Primary Hyperoxaluria Drug Market
Table Key Manufacturers Primary Hyperoxaluria Drug Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Hyperoxaluria Drug
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Primary Hyperoxaluria Drug Sales (K Units) by Region (2015-2020)
Table Global Primary Hyperoxaluria Drug Sales Market Share by Region (2015-2019)
Figure Global Primary Hyperoxaluria Drug Sales Market Share by Region (2015-2019)
Figure Global Primary Hyperoxaluria Drug Sales Market Share by Region in 2018
Table Global Primary Hyperoxaluria Drug Revenue (Million US$) by Region (2015-2020)
Table Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2015-2020)
Figure Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2015-2020)
Figure Global Primary Hyperoxaluria Drug Revenue Market Share by Region in 2019
Table Global Primary Hyperoxaluria Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Primary Hyperoxaluria Drug Sales (K Units) Growth Rate (2015-2020)
Table North America Primary Hyperoxaluria Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Primary Hyperoxaluria Drug Sales (K Units) Growth Rate (2015-2020)
Table Europe Primary Hyperoxaluria Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Primary Hyperoxaluria Drug Sales (K Units) Growth Rate (2015-2020)
Table Japan Primary Hyperoxaluria Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Primary Hyperoxaluria Drug Sales (K Units) Growth Rate (2015-2020)
Table China Primary Hyperoxaluria Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Primary Hyperoxaluria Drug Sales by Type (2015-2020)
Table Global Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Figure Global Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Table Global Primary Hyperoxaluria Drug Revenue by Type (2015-2020)
Table Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2015-2020)
Figure Global Primary Hyperoxaluria Drug Revenue Market Share by Type in 2019
Figure Global ALLN-230 Sales Growth Rate (2015-2020)
Figure Global ALLN-230 Price (2015-2020)
Figure Global DCR-PHXC Sales Growth Rate (2015-2020)
Figure Global DCR-PHXC Price (2015-2020)
Figure Global ALN-GO1 Sales Growth Rate (2015-2020)
Figure Global ALN-GO1 Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Primary Hyperoxaluria Drug Sales by Application (2015-2020)
Table Global Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Figure Global Primary Hyperoxaluria Drug Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Primary Hyperoxaluria Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Primary Hyperoxaluria Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Primary Hyperoxaluria Drug Price and Trend Forecast (2020-2025)
Table Global Primary Hyperoxaluria Drug Sales (K Units) Forecast by Region (2020-2025)
Figure Global Primary Hyperoxaluria Drug Production Market Share Forecast by Region (2020-2025)
Figure North America Primary Hyperoxaluria Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Primary Hyperoxaluria Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Primary Hyperoxaluria Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Primary Hyperoxaluria Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Primary Hyperoxaluria Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Primary Hyperoxaluria Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Primary Hyperoxaluria Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Primary Hyperoxaluria Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Allena Pharmaceuticals Inc Company Profile
Figure Primary Hyperoxaluria Drug Product Picture and Specifications of Allena Pharmaceuticals Inc
Table Primary Hyperoxaluria Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Market Share (2018-2020)
Table Allena Pharmaceuticals Inc Main Business
Table Allena Pharmaceuticals Inc Recent Development
Table Intellia Therapeutics Inc Company Profile
Figure Primary Hyperoxaluria Drug Product Picture and Specifications of Intellia Therapeutics Inc
Table Primary Hyperoxaluria Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Intellia Therapeutics Inc Primary Hyperoxaluria Drug Market Share (2018-2020)
Table Intellia Therapeutics Inc Main Business
Table Intellia Therapeutics Inc Recent Development
Table Alnylam Pharmaceuticals Inc Company Profile
Figure Primary Hyperoxaluria Drug Product Picture and Specifications of Alnylam Pharmaceuticals Inc
Table Primary Hyperoxaluria Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Market Share (2018-2020)
Table Alnylam Pharmaceuticals Inc Main Business
Table Alnylam Pharmaceuticals Inc Recent Development
Table Dicerna Pharmaceuticals Inc Company Profile
Figure Primary Hyperoxaluria Drug Product Picture and Specifications of Dicerna Pharmaceuticals Inc
Table Primary Hyperoxaluria Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Market Share (2018-2020)
Table Dicerna Pharmaceuticals Inc Main Business
Table Dicerna Pharmaceuticals Inc Recent Development
Table OxThera AB Company Profile
Figure Primary Hyperoxaluria Drug Product Picture and Specifications of OxThera AB
Table Primary Hyperoxaluria Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure OxThera AB Primary Hyperoxaluria Drug Market Share (2018-2020)
Table OxThera AB Main Business
Table OxThera AB Recent Development
Table of Appendix